nodes	percent_of_prediction	percent_of_DWPC	metapath
Bisoprolol—CYP3A4—Temozolomide—malignant glioma	0.441	1	CbGbCtD
Bisoprolol—Paresis—Temozolomide—malignant glioma	0.0189	0.0342	CcSEcCtD
Bisoprolol—Skin hyperpigmentation—Carmustine—malignant glioma	0.012	0.0217	CcSEcCtD
Bisoprolol—Encephalopathy—Carmustine—malignant glioma	0.0111	0.0201	CcSEcCtD
Bisoprolol—Aphasia—Carmustine—malignant glioma	0.011	0.0199	CcSEcCtD
Bisoprolol—Embolism—Temozolomide—malignant glioma	0.0107	0.0194	CcSEcCtD
Bisoprolol—Aphasia—Temozolomide—malignant glioma	0.0106	0.0192	CcSEcCtD
Bisoprolol—Hyperaesthesia—Temozolomide—malignant glioma	0.00877	0.0159	CcSEcCtD
Bisoprolol—Speech disorder—Carmustine—malignant glioma	0.00828	0.015	CcSEcCtD
Bisoprolol—Speech disorder—Temozolomide—malignant glioma	0.008	0.0145	CcSEcCtD
Bisoprolol—Breast pain—Temozolomide—malignant glioma	0.00789	0.0143	CcSEcCtD
Bisoprolol—Viral infection—Temozolomide—malignant glioma	0.00762	0.0138	CcSEcCtD
Bisoprolol—Hearing impaired—Temozolomide—malignant glioma	0.00723	0.0131	CcSEcCtD
Bisoprolol—Neck pain—Carmustine—malignant glioma	0.00721	0.0131	CcSEcCtD
Bisoprolol—Respiratory failure—Temozolomide—malignant glioma	0.00701	0.0127	CcSEcCtD
Bisoprolol—Coma—Carmustine—malignant glioma	0.00651	0.0118	CcSEcCtD
Bisoprolol—Abnormal vision—Carmustine—malignant glioma	0.00621	0.0112	CcSEcCtD
Bisoprolol—Abnormal vision—Temozolomide—malignant glioma	0.006	0.0109	CcSEcCtD
Bisoprolol—Ear pain—Temozolomide—malignant glioma	0.00586	0.0106	CcSEcCtD
Bisoprolol—Eye pain—Carmustine—malignant glioma	0.00573	0.0104	CcSEcCtD
Bisoprolol—Injury—Carmustine—malignant glioma	0.00563	0.0102	CcSEcCtD
Bisoprolol—Vascular purpura—Temozolomide—malignant glioma	0.00559	0.0101	CcSEcCtD
Bisoprolol—Eye pain—Temozolomide—malignant glioma	0.00554	0.01	CcSEcCtD
Bisoprolol—Hot flush—Temozolomide—malignant glioma	0.00534	0.00967	CcSEcCtD
Bisoprolol—Dermatitis exfoliative—Temozolomide—malignant glioma	0.0053	0.00959	CcSEcCtD
Bisoprolol—Menopausal symptoms—Temozolomide—malignant glioma	0.0053	0.00959	CcSEcCtD
Bisoprolol—Purpura—Temozolomide—malignant glioma	0.00518	0.00939	CcSEcCtD
Bisoprolol—Affect lability—Temozolomide—malignant glioma	0.00492	0.0089	CcSEcCtD
Bisoprolol—Mood swings—Temozolomide—malignant glioma	0.00473	0.00857	CcSEcCtD
Bisoprolol—Muscular weakness—Carmustine—malignant glioma	0.00456	0.00826	CcSEcCtD
Bisoprolol—Breast disorder—Temozolomide—malignant glioma	0.00452	0.00817	CcSEcCtD
Bisoprolol—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.0045	0.00815	CcSEcCtD
Bisoprolol—Muscular weakness—Temozolomide—malignant glioma	0.00441	0.00798	CcSEcCtD
Bisoprolol—Sweating increased—Temozolomide—malignant glioma	0.00421	0.00762	CcSEcCtD
Bisoprolol—Bronchitis—Temozolomide—malignant glioma	0.00415	0.00752	CcSEcCtD
Bisoprolol—Chlorphenesin—BCHE—malignant glioma	0.00412	0.684	CrCbGaD
Bisoprolol—Pneumonia—Carmustine—malignant glioma	0.00401	0.00726	CcSEcCtD
Bisoprolol—Erectile dysfunction—Temozolomide—malignant glioma	0.00398	0.0072	CcSEcCtD
Bisoprolol—Depression—Carmustine—malignant glioma	0.00397	0.00719	CcSEcCtD
Bisoprolol—Photosensitivity reaction—Temozolomide—malignant glioma	0.00394	0.00714	CcSEcCtD
Bisoprolol—Weight increased—Temozolomide—malignant glioma	0.00393	0.00711	CcSEcCtD
Bisoprolol—Urinary tract infection—Carmustine—malignant glioma	0.00387	0.00701	CcSEcCtD
Bisoprolol—Pneumonia—Temozolomide—malignant glioma	0.00387	0.00701	CcSEcCtD
Bisoprolol—Depression—Temozolomide—malignant glioma	0.00384	0.00695	CcSEcCtD
Bisoprolol—Urinary tract infection—Temozolomide—malignant glioma	0.00374	0.00678	CcSEcCtD
Bisoprolol—Hepatobiliary disease—Temozolomide—malignant glioma	0.00364	0.00659	CcSEcCtD
Bisoprolol—Sinusitis—Temozolomide—malignant glioma	0.00361	0.00654	CcSEcCtD
Bisoprolol—Hallucination—Carmustine—malignant glioma	0.00356	0.00644	CcSEcCtD
Bisoprolol—Hypoaesthesia—Carmustine—malignant glioma	0.00356	0.00644	CcSEcCtD
Bisoprolol—Oedema peripheral—Carmustine—malignant glioma	0.00352	0.00638	CcSEcCtD
Bisoprolol—Connective tissue disorder—Carmustine—malignant glioma	0.00352	0.00636	CcSEcCtD
Bisoprolol—Hepatitis—Temozolomide—malignant glioma	0.00346	0.00626	CcSEcCtD
Bisoprolol—Visual impairment—Carmustine—malignant glioma	0.00345	0.00624	CcSEcCtD
Bisoprolol—Hypoaesthesia—Temozolomide—malignant glioma	0.00344	0.00623	CcSEcCtD
Bisoprolol—Hallucination—Temozolomide—malignant glioma	0.00344	0.00623	CcSEcCtD
Bisoprolol—Pharyngitis—Temozolomide—malignant glioma	0.00343	0.00621	CcSEcCtD
Bisoprolol—Oedema peripheral—Temozolomide—malignant glioma	0.00341	0.00616	CcSEcCtD
Bisoprolol—Connective tissue disorder—Temozolomide—malignant glioma	0.0034	0.00615	CcSEcCtD
Bisoprolol—Eye disorder—Carmustine—malignant glioma	0.00334	0.00605	CcSEcCtD
Bisoprolol—Visual impairment—Temozolomide—malignant glioma	0.00333	0.00603	CcSEcCtD
Bisoprolol—Flushing—Carmustine—malignant glioma	0.00332	0.00601	CcSEcCtD
Bisoprolol—Eye disorder—Temozolomide—malignant glioma	0.00323	0.00585	CcSEcCtD
Bisoprolol—Tinnitus—Temozolomide—malignant glioma	0.00322	0.00583	CcSEcCtD
Bisoprolol—Flushing—Temozolomide—malignant glioma	0.00321	0.00581	CcSEcCtD
Bisoprolol—Cardiac disorder—Temozolomide—malignant glioma	0.00321	0.00581	CcSEcCtD
Bisoprolol—Arrhythmia—Carmustine—malignant glioma	0.0032	0.00578	CcSEcCtD
Bisoprolol—Alopecia—Carmustine—malignant glioma	0.00316	0.00572	CcSEcCtD
Bisoprolol—Angiopathy—Temozolomide—malignant glioma	0.00314	0.00568	CcSEcCtD
Bisoprolol—Mental disorder—Carmustine—malignant glioma	0.00313	0.00567	CcSEcCtD
Bisoprolol—Mediastinal disorder—Temozolomide—malignant glioma	0.00312	0.00564	CcSEcCtD
Bisoprolol—Erythema—Carmustine—malignant glioma	0.00311	0.00564	CcSEcCtD
Bisoprolol—Alopecia—Temozolomide—malignant glioma	0.00305	0.00553	CcSEcCtD
Bisoprolol—Mental disorder—Temozolomide—malignant glioma	0.00303	0.00548	CcSEcCtD
Bisoprolol—Back pain—Carmustine—malignant glioma	0.00301	0.00545	CcSEcCtD
Bisoprolol—Erythema—Temozolomide—malignant glioma	0.00301	0.00545	CcSEcCtD
Bisoprolol—Dysgeusia—Temozolomide—malignant glioma	0.00295	0.00533	CcSEcCtD
Bisoprolol—Tremor—Carmustine—malignant glioma	0.00292	0.00528	CcSEcCtD
Bisoprolol—Back pain—Temozolomide—malignant glioma	0.00291	0.00527	CcSEcCtD
Bisoprolol—Agitation—Carmustine—malignant glioma	0.00286	0.00518	CcSEcCtD
Bisoprolol—Tremor—Temozolomide—malignant glioma	0.00282	0.0051	CcSEcCtD
Bisoprolol—Ill-defined disorder—Temozolomide—malignant glioma	0.00279	0.00505	CcSEcCtD
Bisoprolol—Agitation—Temozolomide—malignant glioma	0.00277	0.00501	CcSEcCtD
Bisoprolol—Angioedema—Temozolomide—malignant glioma	0.00275	0.00498	CcSEcCtD
Bisoprolol—Malaise—Temozolomide—malignant glioma	0.00271	0.00491	CcSEcCtD
Bisoprolol—Vertigo—Temozolomide—malignant glioma	0.0027	0.00489	CcSEcCtD
Bisoprolol—Palpitations—Temozolomide—malignant glioma	0.00266	0.00481	CcSEcCtD
Bisoprolol—Chest pain—Carmustine—malignant glioma	0.00265	0.0048	CcSEcCtD
Bisoprolol—Myalgia—Carmustine—malignant glioma	0.00265	0.0048	CcSEcCtD
Bisoprolol—Anxiety—Carmustine—malignant glioma	0.00264	0.00478	CcSEcCtD
Bisoprolol—Cough—Temozolomide—malignant glioma	0.00263	0.00475	CcSEcCtD
Bisoprolol—Confusional state—Carmustine—malignant glioma	0.00256	0.00464	CcSEcCtD
Bisoprolol—Myalgia—Temozolomide—malignant glioma	0.00256	0.00464	CcSEcCtD
Bisoprolol—Arthralgia—Temozolomide—malignant glioma	0.00256	0.00464	CcSEcCtD
Bisoprolol—Anxiety—Temozolomide—malignant glioma	0.00255	0.00462	CcSEcCtD
Bisoprolol—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00254	0.00461	CcSEcCtD
Bisoprolol—Oedema—Carmustine—malignant glioma	0.00254	0.0046	CcSEcCtD
Bisoprolol—Discomfort—Temozolomide—malignant glioma	0.00253	0.00458	CcSEcCtD
Bisoprolol—Infection—Carmustine—malignant glioma	0.00253	0.00457	CcSEcCtD
Bisoprolol—Dry mouth—Temozolomide—malignant glioma	0.00251	0.00454	CcSEcCtD
Bisoprolol—Thrombocytopenia—Carmustine—malignant glioma	0.00249	0.0045	CcSEcCtD
Bisoprolol—Tachycardia—Carmustine—malignant glioma	0.00248	0.00449	CcSEcCtD
Bisoprolol—Confusional state—Temozolomide—malignant glioma	0.00248	0.00448	CcSEcCtD
Bisoprolol—Oedema—Temozolomide—malignant glioma	0.00246	0.00445	CcSEcCtD
Bisoprolol—Infection—Temozolomide—malignant glioma	0.00244	0.00442	CcSEcCtD
Bisoprolol—Nervous system disorder—Temozolomide—malignant glioma	0.00241	0.00436	CcSEcCtD
Bisoprolol—Thrombocytopenia—Temozolomide—malignant glioma	0.0024	0.00435	CcSEcCtD
Bisoprolol—Skin disorder—Temozolomide—malignant glioma	0.00239	0.00432	CcSEcCtD
Bisoprolol—Hypotension—Carmustine—malignant glioma	0.00237	0.0043	CcSEcCtD
Bisoprolol—Hyperhidrosis—Temozolomide—malignant glioma	0.00237	0.0043	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00232	0.00419	CcSEcCtD
Bisoprolol—Insomnia—Carmustine—malignant glioma	0.0023	0.00416	CcSEcCtD
Bisoprolol—Paraesthesia—Carmustine—malignant glioma	0.00228	0.00413	CcSEcCtD
Bisoprolol—Dyspnoea—Carmustine—malignant glioma	0.00227	0.0041	CcSEcCtD
Bisoprolol—Somnolence—Carmustine—malignant glioma	0.00226	0.00409	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00224	0.00405	CcSEcCtD
Bisoprolol—Insomnia—Temozolomide—malignant glioma	0.00222	0.00402	CcSEcCtD
Bisoprolol—Paraesthesia—Temozolomide—malignant glioma	0.00221	0.00399	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Carmustine—malignant glioma	0.00219	0.00397	CcSEcCtD
Bisoprolol—Dyspnoea—Temozolomide—malignant glioma	0.00219	0.00396	CcSEcCtD
Bisoprolol—Somnolence—Temozolomide—malignant glioma	0.00218	0.00395	CcSEcCtD
Bisoprolol—Pain—Carmustine—malignant glioma	0.00217	0.00393	CcSEcCtD
Bisoprolol—Constipation—Carmustine—malignant glioma	0.00217	0.00393	CcSEcCtD
Bisoprolol—Dyspepsia—Temozolomide—malignant glioma	0.00216	0.00391	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00212	0.00384	CcSEcCtD
Bisoprolol—Fatigue—Temozolomide—malignant glioma	0.00212	0.00383	CcSEcCtD
Bisoprolol—Constipation—Temozolomide—malignant glioma	0.0021	0.0038	CcSEcCtD
Bisoprolol—Pain—Temozolomide—malignant glioma	0.0021	0.0038	CcSEcCtD
Bisoprolol—Feeling abnormal—Carmustine—malignant glioma	0.00209	0.00379	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Carmustine—malignant glioma	0.00208	0.00376	CcSEcCtD
Bisoprolol—Feeling abnormal—Temozolomide—malignant glioma	0.00202	0.00366	CcSEcCtD
Bisoprolol—Body temperature increased—Carmustine—malignant glioma	0.00201	0.00364	CcSEcCtD
Bisoprolol—Abdominal pain—Carmustine—malignant glioma	0.00201	0.00364	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Temozolomide—malignant glioma	0.00201	0.00364	CcSEcCtD
Bisoprolol—Urticaria—Temozolomide—malignant glioma	0.00195	0.00353	CcSEcCtD
Bisoprolol—Abdominal pain—Temozolomide—malignant glioma	0.00194	0.00351	CcSEcCtD
Bisoprolol—Body temperature increased—Temozolomide—malignant glioma	0.00194	0.00351	CcSEcCtD
Bisoprolol—Chlorphenesin—PTGS2—malignant glioma	0.0019	0.315	CrCbGaD
Bisoprolol—Hypersensitivity—Carmustine—malignant glioma	0.00187	0.00339	CcSEcCtD
Bisoprolol—Asthenia—Carmustine—malignant glioma	0.00182	0.0033	CcSEcCtD
Bisoprolol—Hypersensitivity—Temozolomide—malignant glioma	0.00181	0.00328	CcSEcCtD
Bisoprolol—Asthenia—Temozolomide—malignant glioma	0.00176	0.00319	CcSEcCtD
Bisoprolol—Diarrhoea—Carmustine—malignant glioma	0.00174	0.00315	CcSEcCtD
Bisoprolol—Pruritus—Temozolomide—malignant glioma	0.00174	0.00315	CcSEcCtD
Bisoprolol—Dizziness—Carmustine—malignant glioma	0.00168	0.00304	CcSEcCtD
Bisoprolol—Diarrhoea—Temozolomide—malignant glioma	0.00168	0.00304	CcSEcCtD
Bisoprolol—Dizziness—Temozolomide—malignant glioma	0.00162	0.00294	CcSEcCtD
Bisoprolol—Vomiting—Carmustine—malignant glioma	0.00162	0.00293	CcSEcCtD
Bisoprolol—Rash—Carmustine—malignant glioma	0.0016	0.0029	CcSEcCtD
Bisoprolol—Dermatitis—Carmustine—malignant glioma	0.0016	0.0029	CcSEcCtD
Bisoprolol—Headache—Carmustine—malignant glioma	0.00159	0.00288	CcSEcCtD
Bisoprolol—Vomiting—Temozolomide—malignant glioma	0.00156	0.00283	CcSEcCtD
Bisoprolol—Rash—Temozolomide—malignant glioma	0.00155	0.0028	CcSEcCtD
Bisoprolol—Dermatitis—Temozolomide—malignant glioma	0.00155	0.0028	CcSEcCtD
Bisoprolol—Headache—Temozolomide—malignant glioma	0.00154	0.00279	CcSEcCtD
Bisoprolol—Nausea—Carmustine—malignant glioma	0.00151	0.00273	CcSEcCtD
Bisoprolol—Nausea—Temozolomide—malignant glioma	0.00146	0.00264	CcSEcCtD
